Summary
- Current Price
- As of today, DMAC price is $6.89, down -5.49% on
- Current Price All-Time High
- DMAC price is currently -84.67% below its historical high of $44.94 set on
- Market Cap
- DMAC current market cap is $359M, up +69.14% over the past 365 days
- PE Ratio
- DMAC PE ratio is unknown
- Revenue
- DMAC current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- The next earnings release for DMAC is on
Profile
| Metric | Value |
|---|---|
| Full Name | DiaMedica Therapeutics Inc. |
| Ticker | NASDAQ: DMAC |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | diamedica.com |
| Employees | 27 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $6.89 | ||
| Price, 1D Change | -5.49% | |
| $359M | ||
| - | ||
| - | ||
| 1.47 | ||
| $0 | ||
| Revenue, 1Y Change | 0.00% | |
| -$0.61 | ||
| EPS, 1Y Change | -1.66% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:20 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$0.61 | ||
| EPS Estimate | -$0.68 | |
| EPS Est. Change | -13.06% | |
| $0.00 | ||
| Revenue Estimate | - | |
| Revenue Est. Change | - | |
| $6.89 | ||
| Price Target | - | $13.00 |
| Price Tgt. Change | - | +88.68% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.60 | -$0.60 | +0.82% | |
| -$0.59 | -$0.61 | -2.11% | |
| -$0.68 | N/A | -13.06% | |
| -$0.76 | N/A | -24.96% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| - | N/A | - | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| +39.19% | ||
| +333.33% | ||
| +69.14% | ||
| +752.85% | ||
| 0.00% | ||
| 0.00% | ||
| -1.66% | ||
| +7.53% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| $6.89 | ||
| $6.68 | ||
| SMA 200 vs Price | -3.02% | |
| $7.99 | ||
| SMA 50 vs Price | +15.94% | |
| 1.47 | ||
| $0.46 | ||
| 36.57 | ||
| 62.67% | ||
| 72.01% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| -$0.61 | ||
| -$39.00K | ||
| - | ||
| -$26.68M | ||
| - | ||
| -$24.44M | ||
| - | ||
| -$26.64M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.01 | ||
| 8.28 | ||
| 8.28 | ||
| - | ||
| - | ||
| 33.15 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| 6.95 | ||
| -9.05 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $40.72M | ||
| $3.03M | ||
| $46.35M | ||
| $44.61M | ||
| $5.63M | ||
| $5.39M | ||
| $340.00K | ||
| $103.00K | ||
| $940.00K |
Expenses
| Metric | Date | Value |
|---|---|---|
| $26.68M | ||
| $26.68M | ||
| $39.00K | ||
| $7.62M | ||
| $39.00K | ||
| $0.00 | ||
| $30.00K |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$22.08M | ||
| $8.56M | ||
| $11.99M | ||
| $25.00K | ||
| -$22.10M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Cantor Fitzgerald | ||
| HC Wainwright & Co. | → | |
| Lake Street | → | |
| HC Wainwright & Co. | → | |
| Craig-Hallum | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. |
Analyst sentiment
Institutional ownership
Screeners with DMAC
FAQ
What is the ticker symbol for DiaMedica Therapeutics Inc.?
The ticker symbol for DiaMedica Therapeutics Inc. is NASDAQ:DMAC
Does DiaMedica Therapeutics Inc. pay dividends?
No, DiaMedica Therapeutics Inc. does not pay dividends
What sector is DiaMedica Therapeutics Inc. in?
DiaMedica Therapeutics Inc. is in the Healthcare sector
What industry is DiaMedica Therapeutics Inc. in?
DiaMedica Therapeutics Inc. is in the Biotechnology industry
What country is DiaMedica Therapeutics Inc. based in?
DiaMedica Therapeutics Inc. is headquartered in United States
When did DiaMedica Therapeutics Inc. go public?
DiaMedica Therapeutics Inc. initial public offering (IPO) was on August 3, 2012
Is DiaMedica Therapeutics Inc. in the S&P 500?
No, DiaMedica Therapeutics Inc. is not included in the S&P 500 index
Is DiaMedica Therapeutics Inc. in the NASDAQ 100?
No, DiaMedica Therapeutics Inc. is not included in the NASDAQ 100 index
Is DiaMedica Therapeutics Inc. in the Dow Jones?
No, DiaMedica Therapeutics Inc. is not included in the Dow Jones index
When was DiaMedica Therapeutics Inc. last earnings report?
DiaMedica Therapeutics Inc.'s most recent earnings report was on November 12, 2025
When does DiaMedica Therapeutics Inc. report earnings?
The next expected earnings date for DiaMedica Therapeutics Inc. is March 30, 2026
Data Sources & References
- DMAC Official Website www.diamedica.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1401040/000143774925034469/0001437749-25-034469-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1401040/000143774925008018/0001437749-25-008018-index.htm
- DMAC Profile on Yahoo Finance finance.yahoo.com/quote/DMAC
- DMAC Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/dmac